21 May 2013
Keywords: Biogen Idec, Fourth-quarter and full year 2011 financial results
Article | 01 February 2012
US biotech firm Biogen Idec (Nasdaq: BIIB) announced its full year and fourth quarter 2011 results which were slightly ahead of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 February 2012
20 May 2013
© 2013 thepharmaletter.com